Susceptibility of Nrf2-Null Mice to Steatohepatitis and Cirrhosis upon Consumption of a High-Fat Diet Is Associated with Oxidative Stress, Perturbation of the Unfolded Protein Response, and Disturbance in the Expression of Metabolic Enzymes but Not with Insulin Resistance

ABSTRACT Mice lacking the transcription factor NF-E2 p45-related factor 2 (Nrf2) develop more severe nonalcoholic steatohepatitis (NASH), with cirrhosis, than wild-type (Nrf2+/+) mice when fed a high-fat (HF) diet for 24 weeks. Although NASH is usually associated with insulin resistance, HF-fed Nrf2−/− mice exhibited better insulin sensitivity than HF-fed Nrf2+/+ mice. In livers of HF-fed mice, loss of Nrf2 resulted in greater induction of lipogenic genes, lower expression of β-oxidation genes, greater reduction in AMP-activated protein kinase (AMPK) levels, and diminished acetyl coenzyme A (CoA) carboxylase phosphorylation than in the wild-type livers, which is consistent with greater fatty acid (FA) synthesis in Nrf2−/− livers. Moreover, primary Nrf2−/− hepatocytes displayed lower glucose and FA oxidation than Nrf2+/+ hepatocytes, with FA oxidation partially rescued by treatment with AMPK activators. The unfolded protein response (UPR) was perturbed in control regular-chow (RC)-fed Nrf2−/− mouse livers, and this was associated with constitutive activation of NF-κB and JNK, along with upregulation of inflammatory genes. The HF diet elicited an antioxidant response in Nrf2+/+ livers, and as this was compromised in Nrf2−/− livers, they suffered oxidative stress. Therefore, Nrf2 protects against NASH by suppressing lipogenesis, supporting mitochondrial function, increasing the threshold for the UPR and inflammation, and enabling adaptation to HF-diet-induced oxidative stress.

[1]  R. Kaufman,et al.  Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. , 2014, Antioxidants & redox signaling.

[2]  X. Wang,et al.  Degradation of Keap1 activates BH3-only proteins Bim and PUMA during hepatocyte lipoapoptosis , 2014, Cell Death and Differentiation.

[3]  F. Bellanti,et al.  Free radical biology for medicine: learning from nonalcoholic fatty liver disease. , 2013, Free radical biology & medicine.

[4]  D. Rutkowski,et al.  The Stress-Regulated Transcription Factor CHOP Promotes Hepatic Inflammatory Gene Expression, Fibrosis, and Oncogenesis , 2013, PLoS genetics.

[5]  Wen Hou,et al.  Emerging Role of High-Mobility Group Box 1 (HMGB1) in Liver Diseases , 2013, Molecular Medicine.

[6]  Yanhua Zhang,et al.  Nrf2 deletion causes “benign” simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet , 2013, Lipids in Health and Disease.

[7]  Masayuki Yamamoto,et al.  Keap1 knockdown increases markers of metabolic syndrome after long-term high fat diet feeding. , 2013, Free radical biology & medicine.

[8]  Hye-Youn Cho Genomic Structure and Variation of Nuclear Factor (Erythroid-Derived 2)-Like 2 , 2013, Oxidative medicine and cellular longevity.

[9]  J. G. Kenna,et al.  The gasotransmitter hydrogen sulfide induces nrf2-target genes by inactivating the keap1 ubiquitin ligase substrate adaptor through formation of a disulfide bond between cys-226 and cys-613. , 2013, Antioxidants & redox signaling.

[10]  J. Iredale,et al.  Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation. , 2013, Biochimica et biophysica acta.

[11]  Takafumi Suzuki,et al.  Toward clinical application of the Keap1-Nrf2 pathway. , 2013, Trends in pharmacological sciences.

[12]  M. Lotze,et al.  HMGB1 in Cancer: Good, Bad, or Both? , 2013, Clinical Cancer Research.

[13]  A. Sugawara,et al.  The Keap1-Nrf2 System Prevents Onset of Diabetes Mellitus , 2013, Molecular and Cellular Biology.

[14]  Masayuki Yamamoto,et al.  Deletion of Nrf2 leads to rapid progression of steatohepatitis in mice fed atherogenic plus high-fat diet , 2013, Journal of Gastroenterology.

[15]  D. Chartoumpekis,et al.  Hepatic Gene Expression Profiling in Nrf2 Knockout Mice after Long-Term High-Fat Diet-Induced Obesity , 2013, Oxidative medicine and cellular longevity.

[16]  D. Rutkowski,et al.  C/EBP Homologous Protein (CHOP) Contributes to Suppression of Metabolic Genes during Endoplasmic Reticulum Stress in the Liver* , 2012, The Journal of Biological Chemistry.

[17]  Ajay C Donepudi,et al.  Enhanced Nrf2 Activity Worsens Insulin Resistance, Impairs Lipid Accumulation in Adipose Tissue, and Increases Hepatic Steatosis in Leptin-Deficient Mice , 2012, Diabetes.

[18]  T. Ikeda,et al.  Dysregulated expression of fatty acid oxidation enzymes and iron‐regulatory genes in livers of Nrf2‐null mice , 2012, Journal of gastroenterology and hepatology.

[19]  Jie Liu,et al.  Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet. , 2012, Toxicology and applied pharmacology.

[20]  F. Foufelle,et al.  New insights into ER stress-induced insulin resistance , 2012, Trends in Endocrinology & Metabolism.

[21]  L. Gan,et al.  NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications , 2012, Gut and liver.

[22]  Guido Gerken,et al.  The interaction of hepatic lipid and glucose metabolism in liver diseases. , 2012, Journal of hepatology.

[23]  T. Mariani,et al.  Conditional deletion of Nrf2 in airway epithelium exacerbates acute lung injury and impairs the resolution of inflammation. , 2011, American journal of respiratory cell and molecular biology.

[24]  C. Klaassen,et al.  Beneficial role of Nrf2 in regulating NADPH generation and consumption. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[25]  A. Papavassiliou,et al.  Nrf2 Represses FGF21 During Long-Term High-Fat Diet–Induced Obesity in Mice , 2011, Diabetes.

[26]  Won Dong Kim,et al.  Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding. , 2011, Antioxidants & redox signaling.

[27]  J. Speakman,et al.  Reduction in BACE1 decreases body weight, protects against diet-induced obesity and enhances insulin sensitivity in mice , 2011, The Biochemical journal.

[28]  Jonathan C. Cohen,et al.  Human Fatty Liver Disease: Old Questions and New Insights , 2011, Science.

[29]  I. G. Fantus,et al.  Oltipraz upregulates the nuclear respiratory factor 2 alpha subunit (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice , 2011, Diabetologia.

[30]  Lee H. Dicker,et al.  Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity , 2011, Nature.

[31]  B. Neuschwander‐Tetri,et al.  Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings , 2011, Hepatology.

[32]  I. G. Fantus,et al.  Erratum to: Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice , 2011, Diabetologia.

[33]  Jiansheng Huang,et al.  Transcription factor Nrf2 regulates SHP and lipogenic gene expression in hepatic lipid metabolism. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[34]  M. McMahon,et al.  Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals , 2010, Proceedings of the National Academy of Sciences.

[35]  M. McMahon,et al.  Cancer chemoprevention mechanisms mediated through the Keap1-Nrf2 pathway. , 2010, Antioxidants & redox signaling.

[36]  B. Viollet,et al.  Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. , 2010, The Journal of clinical investigation.

[37]  Masayuki Yamamoto,et al.  Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver , 2010, Journal of proteomics.

[38]  C. Klaassen,et al.  Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet. , 2010, Toxicology and applied pharmacology.

[39]  F. Ross,et al.  Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation , 2010, Cell metabolism.

[40]  J. Ntambi,et al.  Genetic control of de novo lipogenesis: role in diet-induced obesity , 2010, Critical reviews in biochemistry and molecular biology.

[41]  I. Hyodo,et al.  Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[42]  J. Hayes,et al.  Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. , 2010, Free radical biology & medicine.

[43]  O. Sansom,et al.  Markedly enhanced colon tumorigenesis in ApcMin mice lacking glutathione S-transferase Pi , 2009, Proceedings of the National Academy of Sciences.

[44]  A. Hevener,et al.  AMPK β1 Deletion Reduces Appetite, Preventing Obesity and Hepatic Insulin Resistance* , 2009, The Journal of Biological Chemistry.

[45]  M. Sporn,et al.  Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. , 2009, European journal of pharmacology.

[46]  Atsushi Fukushima,et al.  Reactive oxygen species enhance insulin sensitivity. , 2009, Cell metabolism.

[47]  D. Scheuner,et al.  Translation attenuation through eIF2alpha phosphorylation prevents oxidative stress and maintains the differentiated state in beta cells. , 2009, Cell metabolism.

[48]  Michael O. Kelleher,et al.  Transcription factor Nrf2 mediates an adaptive response to sulforaphane that protects fibroblasts in vitro against the cytotoxic effects of electrophiles, peroxides and redox-cycling agents. , 2009, Toxicology and applied pharmacology.

[49]  M. Sporn,et al.  Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. , 2009, Carcinogenesis.

[50]  S. Luquet,et al.  GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. , 2009, The Journal of clinical investigation.

[51]  M. Katze,et al.  UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators. , 2008, Developmental cell.

[52]  R. Kaufman,et al.  Antioxidants reduce endoplasmic reticulum stress and improve protein secretion , 2008, Proceedings of the National Academy of Sciences.

[53]  Masayuki Yamamoto,et al.  The Antioxidant Defense System Keap1-Nrf2 Comprises a Multiple Sensing Mechanism for Responding to a Wide Range of Chemical Compounds , 2008, Molecular and Cellular Biology.

[54]  Randal J. Kaufman,et al.  From endoplasmic-reticulum stress to the inflammatory response , 2008, Nature.

[55]  L. Glimcher,et al.  Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1 , 2008, Science.

[56]  D. Ron,et al.  Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice. , 2008, Cell metabolism.

[57]  M. Diez,et al.  Liver lipid metabolism. , 2008, Journal of animal physiology and animal nutrition.

[58]  C. Klaassen,et al.  NF-E2-Related Factor 2 Inhibits Lipid Accumulation and Oxidative Stress in Mice Fed a High-Fat Diet , 2008, Journal of Pharmacology and Experimental Therapeutics.

[59]  S. Mantena,et al.  Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. , 2008, Free radical biology & medicine.

[60]  R. Eckel,et al.  CCAAT/Enhancer-binding Protein β Deletion Reduces Adiposity, Hepatic Steatosis, and Diabetes in Leprdb/db Mice* , 2007, Journal of Biological Chemistry.

[61]  U. Meyer,et al.  In the regulation of cytochrome P450 genes, phenobarbital targets LKB1 for necessary activation of AMP-activated protein kinase , 2007, Proceedings of the National Academy of Sciences.

[62]  Shyam Biswal,et al.  Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. , 2007, Annual review of pharmacology and toxicology.

[63]  B. Staels,et al.  The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[64]  Mark Hannink,et al.  Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex , 2004, Molecular and Cellular Biology.

[65]  L. Glimcher,et al.  Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.

[66]  Masayuki Yamamoto,et al.  Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2 , 2004, Molecular and Cellular Biology.

[67]  J. Horton,et al.  Molecular mediators of hepatic steatosis and liver injury. , 2004, The Journal of clinical investigation.

[68]  J. Alan Diehl,et al.  PERK-dependent Activation of Nrf2 Contributes to Redox Homeostasis and Cell Survival following Endoplasmic Reticulum Stress* , 2004, Journal of Biological Chemistry.

[69]  K. Itoh,et al.  Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. , 2003, The Biochemical journal.

[70]  K. Itoh,et al.  Keap1-dependent Proteasomal Degradation of Transcription Factor Nrf2 Contributes to the Negative Regulation of Antioxidant Response Element-driven Gene Expression* , 2003, Journal of Biological Chemistry.

[71]  C. Wolf,et al.  Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. , 2002, The Biochemical journal.

[72]  J. Hayes,et al.  Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver. , 2000, Cancer research.

[73]  D. Hardie,et al.  AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes. , 1999, American journal of physiology. Endocrinology and metabolism.

[74]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[75]  K. Itoh,et al.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. , 1997, Biochemical and biophysical research communications.

[76]  H. Gilbert,et al.  Oxidative inactivation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and subunit cross-linking involve different dithiol/disulfide centers. , 1993, The Journal of biological chemistry.

[77]  A. Sanyal,et al.  Lipotoxicity in NASH. , 2012, Journal of hepatology.

[78]  C. Palmeira,et al.  Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. , 2012, Free radical biology & medicine.

[79]  Ze Zheng,et al.  Measurement of ER stress response and inflammation in the mouse model of nonalcoholic fatty liver disease. , 2011, Methods in enzymology.

[80]  T. Tiganis Reactive oxygen species and insulin resistance: the good, the bad and the ugly. , 2011, Trends in pharmacological sciences.

[81]  杉本 浩一 Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice , 2011 .

[82]  F. Ross,et al.  Use of Cells Expressing gamma Subunit Variants to Identify Diverse Mechanisms of AMPK Activation , 2010 .

[83]  S. Rensen,et al.  Gastrointestinal , Hepatobiliary and Pancreatic Pathology Increased Hepatic Myeloperoxidase Activity in Obese Subjects with Nonalcoholic Steatohepatitis , 2009 .

[84]  C. Klaassen,et al.  NF-E 2-Related Factor 2 Inhibits Lipid Accumulation and Oxidative Stress in Mice Fed a High-Fat Diet , 2008 .

[85]  G. Farrell,et al.  LIVER FAILURE AND LIVER DISEASE Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis , 2006 .

[86]  P. Coates,et al.  Detecting and quantifying apoptosis in tissue sections. , 2004, Methods in molecular biology.